302 related articles for article (PubMed ID: 19321325)
1. Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.
Scuteri A; Najjar SS; Orru' M; Albai G; Strait J; Tarasov KV; Piras MG; Cao A; Schlessinger D; Uda M; Lakatta EG
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):532-41. PubMed ID: 19321325
[TBL] [Abstract][Full Text] [Related]
2. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
Basile J; Houston M; Ferrario CM
J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
[No Abstract] [Full Text] [Related]
3. Change in cardiovascular risk factors in relation to diabetes status: the Tromso Study.
Joseph J; Svartberg J; Njølstad I; Schirmer H
Eur J Prev Cardiol; 2012 Jun; 19(3):551-7. PubMed ID: 21505026
[TBL] [Abstract][Full Text] [Related]
4. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
[TBL] [Abstract][Full Text] [Related]
5. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G
Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091
[TBL] [Abstract][Full Text] [Related]
6. Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech Republic.
Chmelík Z; Vaclová M; Lánská V; Laštůvka J; Vrablík M
Cent Eur J Public Health; 2020 Jun; 28(2):114-119. PubMed ID: 32592555
[TBL] [Abstract][Full Text] [Related]
7. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
[TBL] [Abstract][Full Text] [Related]
9. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
Omboni S; Carabelli G; Ghirardi E; Carugo S
Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
[TBL] [Abstract][Full Text] [Related]
10. Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry.
Schaefer JR; Gitt AK; Sonntag F; Weizel A; Jannowitz C; Karmann B; Pittrow D; Bestehorn K
Vasc Health Risk Manag; 2013; 9():71-80. PubMed ID: 23459022
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.
Tuppin P; Ricci-Renaud P; de Peretti C; Fagot-Campagna A; Gastaldi-Menager C; Danchin N; Alla F; Allemand H
Arch Cardiovasc Dis; 2013 May; 106(5):274-86. PubMed ID: 23769402
[TBL] [Abstract][Full Text] [Related]
12. Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
Roccatagliata D; Avanzini F; Monesi L; Caimi V; Lauri D; Longoni P; Marchioli R; Tombesi M; Tognoni G; Roncaglioni MC;
Vasc Health Risk Manag; 2006; 2(4):507-14. PubMed ID: 17323606
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care.
Emanuel G; Charlton J; Ashworth M; Gulliford MC; Dregan A
Heart; 2016 Dec; 102(24):1957-1962. PubMed ID: 27534979
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular risk profile in 40-year old men and 50-year old women in the Czech Republic: results of a cross-sectional survey].
Vrablík M; Chmelík Z; Lánská V
Vnitr Lek; 2014 Nov; 60(11):991-7. PubMed ID: 25600047
[TBL] [Abstract][Full Text] [Related]
15. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
[TBL] [Abstract][Full Text] [Related]
16. Awareness, treatment, control of hypertension, and associated factors: Results from a Turkish national study.
Dastan I; Erem A; Cetinkaya V
Clin Exp Hypertens; 2018; 40(1):90-98. PubMed ID: 28686064
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study.
Kautzky-Willer A; Stich K; Hintersteiner J; Kautzky A; Kamyar MR; Saukel J; Johnson J; Lemmens-Gruber R
Cardiovasc Diabetol; 2013 May; 12():78. PubMed ID: 23705959
[TBL] [Abstract][Full Text] [Related]
18. The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.
Ferrario CM; Joyner J; Colby C; Exuzides A; Moore M; Simmons D; Bestermann W; Frech-Tamas F
Vasc Health Risk Manag; 2013; 9():391-400. PubMed ID: 23901282
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome is strongly associated with chronic subclinical inflammation in patients achieving optimal low-density lipoprotein-cholesterol levels in secondary prevention of cardiovascular disease.
Matsuo Y; Hashizume T; Shioji S; Akasaka T
Circ J; 2008 Dec; 72(12):2046-50. PubMed ID: 18946171
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on hypertension's prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey.
Dorobantu M; Tautu OF; Dimulescu D; Sinescu C; Gusbeth-Tatomir P; Arsenescu-Georgescu C; Mitu F; Lighezan D; Pop C; Babes K; Giuca A; Branza I; Udrescu M; Herdea V; Darabont R
J Hypertens; 2018 Mar; 36(3):690-700. PubMed ID: 29035940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
